Hrt Financial LP Spectrum Pharmaceuticals Inc Transaction History

Hrt Financial LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.63 - $1.59 $540,692 - $1.36 Million	-858,242 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.27 - $2.42 $1.07 Million - $2.03 Million	838,949 Added 4348.46%	858,242 $1.09 Million
Q3 2021 Nov 15, 2021	BUY	$2.15 - $3.82 $41,479 - $73,699	19,293 New	19,293 $42,000
Q4 2019 Feb 14, 2020	SELL	$3.5 - $10.35 $37,250 - $110,155	-10,643 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$7.03 - $9.7 $74,820 - $103,237	10,643 New	10,643 $88,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.